BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17854831)

  • 1. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
    Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
    J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
    Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
    Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
    Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
    Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.
    Peskind ER; Leverenz J; Farlow MR; Ito RK; Provow SA; Siegel RS; Cleveland M; Morgan CH; Pandian MR; Corbin S; Nochlin D; Schellenberg GD; Raskind MA; Wagner SL
    Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):201-6. PubMed ID: 9437437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
    J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma, red cell, and cerebrospinal fluid folate in Alzheimer's disease].
    Abalan F; Zittoun J; Boutami C; Dugrais G; Manciet G; Decamps A; Antoniol B
    Encephale; 1996; 22(6):430-4. PubMed ID: 10901835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
    Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
    J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased plasma antioxidants in patients with Alzheimer's disease.
    Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
    Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
    Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
    Ahmed N; Ahmed U; Thornalley PJ; Hager K; Fleischer G; Münch G
    J Neurochem; 2005 Jan; 92(2):255-63. PubMed ID: 15663474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
    J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
    Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
    Popp J; Bacher M; Kölsch H; Noelker C; Deuster O; Dodel R; Jessen F
    J Psychiatr Res; 2009 May; 43(8):749-53. PubMed ID: 19038405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
    Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease.
    Smith ER; Nilforooshan R; Weaving G; Tabet N
    J Alzheimers Dis; 2011; 24(2):327-33. PubMed ID: 21239851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease.
    Rentzos M; Michalopoulou M; Nikolaou C; Cambouri C; Rombos A; Dimitrakopoulos A; Kapaki E; Vassilopoulos D
    J Geriatr Psychiatry Neurol; 2004 Dec; 17(4):225-31. PubMed ID: 15533994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.